Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Tranexamic Acid (TXA) Administration in Patients Undergoing Caesarean Delivery (CD).

NCT05759156 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.

NCT NCT05759156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05759156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Tranexamic Acid (TXA) Administration in Patients Undergoing Caesarean Delivery (CD).
Lead sponsor
Dow University of Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2023
Completion date
February 10, 2024
Enrollment
572 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section complications, obstetric anesthesia problems, postpartum hemorrhage